STZ

Business profile & competitive position

Constellation Brands, Inc. operates in the Consumer Defensive sector, specifically the Beverages - Alcoholic industry. It is an international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Its best-known brands include Modelo Especial, Corona Extra, Kim Crawford, Robert Mondavi Winery, and High West. In the U.S., Constellation is the second-largest beer company and the leading seller of imported beer, and Modelo Especial is the #1 beer brand by dollar sales.

Beer dominates the revenue mix. For fiscal 2026, Beer segment net sales were $8,315.2 million, against consolidated net sales of $9,139.0 million. That means beer accounted for roughly 91% of total net sales. The company has repositioned wine and spirits around exclusively higher-end brands, completing the sale and licensing of mainstream wine brands in June 2025.

The margin and return figures support a picture of a mature, brand-driven business. Net margin is 20.1% and return on equity is 23.1%. Those levels point to meaningful pricing power, efficient capital use, and distribution leverage rather than commodity competition. Constellation's low beta of 0.40 also fits the defensive, staples-like cash-flow profile typical of large alcoholic beverage companies.

Financial posture

Constellation Brands currently trades at a $22.4 billion market capitalization with a trailing P/E of 12.5. That multiple sits alongside a 20.1% net margin and a 23.1% ROE. The combination of high profitability, high returns on equity, and a sub-market multiple is the financial profile investors usually associate with a capital-efficient defensive name where growth expectations are priced conservatively.

The stock's current price is $130.88, with a 50-day EMA of $135.20 and an RSI of 42.6. Price is below the 50-day EMA and RSI is near neutral territory, indicating neither overbought nor oversold conditions on that timeframe. These are descriptive levels only; they do not imply a directional outlook.

Strategic priorities & outlook

Constellation's most recent 10-K frames its priorities around delivering long-term total stockholder return through strong brands, advantaged routes to market, disciplined capital deployment, operational efficiency, and ESG advancement.

For the U.S. beer business, the company is focused on maintaining market leadership in the high-end segment, growing its imported beer brands via leading margins and improved operating cash flow, and finding new growth avenues. In fiscal 2027 specifically, it plans to increase distribution for key beer brands, optimize growth through differentiated brand positioning, price-pack architecture, and market prioritization, and invest in the next phase of modular brewery capacity additions.

The capacity buildout is a real balance-sheet commitment. Constellation spent more than $700 million on modular capacity additions in fiscal 2026 and expects approximately $800 million of fiscal 2027 capital expenditures, almost entirely for these activities. It operates breweries in Nava and Obregón and is constructing a third in Veracruz.

In wine and spirits, the focus is margin improvement and growth by expanding across U.S. wholesale, international markets, and direct-to-consumer and hospitality channels. As of February 28, 2026, the company had approximately 9,400 employees, about 20% of whom were covered by collective bargaining agreements.

Macro & geopolitical exposure

As an alcoholic beverage company with a large imported-beer footprint, Constellation is exposed to trade policy, tariffs, currency, input costs, and regulation. Recent headlines about U.S.-Canada tariffs illustrate the sensitivity: an August 24, 2026 Benzinga article noted that Trump's Canada tariffs have revived a headache for U.S. alcohol stocks.

More broadly, the industry faces potential cost pressure from agricultural commodities such as barley and corn, packaging materials like glass and aluminum, and energy and freight. Currency exposure matters because Mexico is central to Constellation's brewing and supply chain; peso-dollar movements can affect both reported results and cash costs. Regulation is another standing factor, including excise taxes, labeling requirements, advertising restrictions, and age-verification rules. Demand can also shift with consumer discretionary pressure during inflationary periods, even though alcohol is typically viewed as a defensive category.

Recent developments

The most recent news flow has been dominated by capital-allocation and policy themes. On August 24, 2026, Seeking Alpha published "Constellation Brands: Berkshire's Exit Doesn't Change Anything," suggesting the exit of a major shareholder should not by itself change the investment thesis. Separately, on August 25, 2026, MarketBeat ran a headline about Berkshire Hathaway boosting a bet on an AI hyperscaler; while that item is not Constellation-specific, it underscores the same capital-rotation story that market watchers have tied to the Berkshire exit narrative.

On August 20, 2026, Constellation announced it will present at the 2026 Barclays Global Consumer Conference on September 8, 2026, according to GlobeNewswire. These events can bring updated commentary on beer volume trends, tariff impacts, and progress on the Veracruz brewery expansion.

Earnings behavior & post-earnings drift

Over the last eight reported quarters, Constellation has beaten expectations 6 out of 8 times, for a 75% beat rate. The average earnings surprise is 7.3%, and the average 5-day post-earnings move is 4.02%, classified as an upward drift.

The last four quarters were all beats, but the price reaction was uneven. On June 30, 2026, Constellation reported EPS of $3.43 versus an estimate of $3.22, a 6.5% beat. The stock fell 1.59% the next day and 6.29% over the following five days. On April 8, 2026, EPS came in at $1.90 against $1.71 estimated, an 11.1% beat, and the stock rose 8.53% the next day and 9.11% over the next five days. On January 7, 2026, EPS was $3.06 versus $2.63 estimated, a 16.3% surprise, producing a 5.32% one-day gain and an 11.3% five-day gain. On October 6, 2025, EPS was $3.63 versus $3.38 estimated, a 7.4% beat, and the stock rose 1.03% the next day and 1.97% over five days.

This history shows that beating estimates does not guarantee a continued move in the same direction. The average 5-day drift is positive only because the April and January 2026 reactions were large enough to offset the latest quarter's negative reaction. The next scheduled earnings release is October 5, 2026 after the close, with a consensus EPS estimate of $3.63.

If you want a fuller picture of how institutional analysts are weighing these factors, including detailed estimates, valuation models, and forward-looking commentary, it is worth reviewing the full institutional verdict for STZ.